Inventor · disambiguated record
Yusheng Xiong
Also filed as: XIONG YUSHENG
35 granted patents·9 pending applications·228 citations·filing 1993–2024
96Inventor score
Files withMERCK SHARP & DOHME14MERCK SHARP & DOHME LLC9MOBIL OIL CORP7MERCK & CO INC4REZUBIO PHARMACEUTICALS CO LTD3
Top patents by PatentIndex Score
44 records- 0193US5453556AOligomerization process for producing synthetic lubricantsMOBIL OIL CORP·Filed 1994·Granted Sep 26, 1995·43 cites·20 claims
- 0291US6653153B2Methods for encoding combinatorial librariesMERCK & CO INC·Filed 2001·Granted Nov 25, 2003·82 cites·20 claims
- 0387US7598285B2Pyrazole derivatives, compositions containing such compounds and methods of useMERCK & CO INC·Filed 2005·Granted Oct 6, 2009·10 cites·23 claims
- 0486US7625938B2Substituted pyrazoles, compositions containing such compounds and methods of useMERCK & CO INC·Filed 2005·Granted Dec 1, 2009·10 cites·9 claims
- 0585US11530244B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2019·Granted Dec 20, 2022·6 cites·15 claims
- 0683US11427616B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2019·Granted Aug 30, 2022·3 cites·48 claims
- 0783US5516954AProcess for preparing long chain alkylaromatic compoundsMOBIL OIL CORP·Filed 1994·Granted May 14, 1996·21 cites·20 claims
- 0880US9382226B2Aldosterone synthase inhibitorsHOYT SCOTT B·Filed 2011·Granted Jul 5, 2016·4 cites·16 claims
- 0979US2025206781A1Pcsk9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1077US7799818B2Pyrazole derivatives, compositions containing such compounds and methods of useMERCK SHARP & DOHME·Filed 2009·Granted Sep 21, 2010·2 cites·10 claims
- 1175US9877957B2Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2MERCK SHARP & DOHME·Filed 2015·Granted Jan 30, 2018·2 cites·16 claims
- 1273US12209145B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 28, 2025·0 cites·29 claims
- 1369US12012468B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2022·Granted Jun 18, 2024·0 cites·15 claims
- 1469US9073929B2Aldosterone synthase inhibitorsHOYT SCOTT B·Filed 2012·Granted Jul 7, 2015·3 cites·20 claims
- 1569US2025073338A1Conjugate compounds and compositionsREZUBIO PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1665US7504425B2Compounds useful in the treatment of anthrax and inhibiting lethal factorMERCK & CO INC·Filed 2003·Granted Mar 17, 2009·2 cites·8 claims
- 1763US5578743ACyclopymerization polymers from non-conjugated dienesMOBIL OIL CORP·Filed 1995·Granted Nov 26, 1996·17 cites·11 claims
- 1863US5545790AProcess for the catalytic cyclodimerization of cyclic olefinsMOBIL OIL CORP·Filed 1993·Granted Aug 13, 1996·7 cites·9 claims
- 1963US2025223281A1Antidiabetic compounds and compositionsREZUBIO PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 2062US11932705B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2022·Granted Mar 19, 2024·0 cites·13 claims
- 2159US12102633B2Spirolactone compoundsQUIXGEN INC·Filed 2023·Granted Oct 1, 2024·0 cites·20 claims
- 2257US2024002354A1Antidiabetic compounds and compositionsREZUBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2357US2024238367A1Compounds for treating conditions related to pcsk9 activityMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2453US11077092B2Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitorMERCK SHARP & DOHME·Filed 2017·Granted Aug 3, 2021·0 cites·15 claims
- 2553US2014235667A1Imidazopyridyl compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2012·Application pending·0 cites
- 2652US11505575B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 22, 2022·0 cites·23 claims
- 2752US9567333B2Triazolopyridyl compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Feb 14, 2017·0 cites·8 claims
- 2852US9518055B2Imidazopyridyl compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Dec 13, 2016·0 cites·12 claims
- 2951US5461181AHeterogeneous catalytic oligomerization of norborneneMOBIL OIL CORP·Filed 1994·Granted Oct 24, 1995·4 cites·9 claims
- 3048US9193724B2Triazolopyridyl compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Nov 24, 2015·0 cites·9 claims
- 3147US12440496B2Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 14, 2025·0 cites·15 claims
- 3247US2022281886A1Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetesMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 3345US11306125B2PCSK9 antagonists bicyclo-compoundsMERCK SHARP & DOHME·Filed 2019·Granted Apr 19, 2022·0 cites·15 claims
- 3445US5750480AAlkylated anisole lubricant basestockMOBIL OIL CORP·Filed 1996·Granted May 12, 1998·10 cites·17 claims
- 3545US2007088070A1Pyrazole derivatives, compositions containing such compounds and methods of usePARMEE EMMA R·Filed 2006·Application pending·0 cites
- 3643US9844553B2Pyrazolopyridyl compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Dec 19, 2017·0 cites·7 claims
- 3743US9522141B2Indazole compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Dec 20, 2016·0 cites·12 claims
- 3842US5461180ACatalytic norbornylation of aromaticsMOBIL OIL CORP·Filed 1994·Granted Oct 24, 1995·2 cites·10 claims
- 3941US9351973B2Pyrazolopyridyl compounds as aldosterone synthase inhibitorsBENNETT D JONATHAN·Filed 2012·Granted May 31, 2016·0 cites·5 claims
- 4039US11541046B2Spirolactone compoundsXIONG YUSHENG·Filed 2018·Granted Jan 3, 2023·0 cites·25 claims
- 4138US11008313B2Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteric bindersMERCK SHARP & DOHME·Filed 2017·Granted May 18, 2021·0 cites·14 claims
- 4237US9828369B2Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2MERCK SHARP & DOHME·Filed 2015·Granted Nov 28, 2017·0 cites·19 claims
- 4337US2015320724A1Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitorGUAN HONG-PING·Filed 2013·Application pending·0 cites
- 4434US10568876B2Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2MERCK SHARP & DOHME·Filed 2015·Granted Feb 25, 2020·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →